When things get SAPpy: Novel insights into complement
The body uses two distinct arms of the immune system to effectively fight off various pathogens, such as bacteria and viruses. The innate immune system is considered the “first responder” and includes the complement system. This system is a key regulator of inflammatory signal amplification and clearance of dead or damaged cells to manage pathogenic infections.
C4BP is a binding protein responsible for the inactivation of complement protein C4b and, consequently, the complement cascade. Interestingly, C4BP is also known to form higher-order structures, or HOS, allowing C4BP to interact with other complement-related proteins. Recently, Tereza Kadavá and a team of scientists at Utrecht University characterized the interactions of C4BP HOS with two of its known binding partners, C4b and serum amyloid protein, or SAP, and identified potential areas of crosstalk between the two binding interactions. The study was published in Molecular & Cellular Proteomics.
Using a combination of mass photometry and high-speed atomic force microscopy, the team determined that C4b formed three different types of complexes with C4BP HOS particles. The most abundant binding conformation consisted of a 1:1 C4BP:C4b binding ratio, while smaller quantities of complexes were bound in ratios of 1:2 or 1:3. Additionally, they determined that these interactions are specifically mediated by C4BP-α chains within the C4BP structure.
Conversely, SAP showed a strong preference for 1:1 binding ratios, which led to the discovery of SAP pentamer engagement with the entire C4BP HOS. By using cross-linking mass spectrometry, Kadavá and her colleagues discovered that SAP interacts with the C4BP HOS via the C4BP oligomerization core. The researchers also noticed that even in the presence of abundant C4BP-α, C4BP-SAP complex formation did not occur, suggesting that this process is mediated separately from C4BP:C4b binding.
This work provides novel proteomic insights into the complement cascade and structurally defines the C4BP-C4b complex for the first time.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.
The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.
Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.
Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.
How copper delivery fuels bacterial respiration
Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.
Revealing the glycoproteome of a cancer subtype
Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.